Key Takeaways
- Cardiac biomarkers are useful tools for the diagnosis, prognostication and management of HFrEF and HFpEF.
- Future approaches should expand beyond biomarker monitoring in established disease states and try to prevent disease through early detection of at risk patients.
Dr David Sim shares the value of cardiac biomarkers – Natriuretic peptide as useful tools for the diagnosis, prognostication and management of heart failure.